Overview

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
0
Participant gender:
All
Summary
The primary purpose of the study is to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Treatments:
Acetaminophen
Hydrocodone
Criteria
Inclusion Criteria:

- Adult male and female subjects who voluntarily sign the informed consent

- Diagnosis of CLBP of 6 months duration

Exclusion Criteria:

- Incapacitated or bedridden subjects

- Subjects with history of surgical or invasive intervention